Harvard Bioscience Inc reports results for the quarter ended in June - Earnings Summary

Harvard Bioscience

06/08/2021 19:34

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly adjusted
earnings of 6 cents​​ per share for the quarter ended in June.
The mean expectation of four analysts for the quarter was
for earnings of 6 cents per share.
* Revenue rose 25.3% to $29.20 million from a year ago; 
analysts expected $27.67 million. 
* Harvard Bioscience Inc's reported EPS for the quarter was a
loss of 1 cents​.
* The mean earnings estimate of analysts had risen by about 5.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Harvard Bioscience Inc shares had fallen by 4.0% this
quarter and gained 86.5% so far this year.
* The company reported a quarterly loss of $410 thousand.
* Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 06:34 p.m.  ​All
figures in US dollars unless otherwise stated